|
Index of reports
> Cases with Abdominal Pain (79)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Sandostatin (Octreotide) where reactions include abdominal pain. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 79 Next >>
Possible Sandostatin side effects in male
Reported by a consumer/non-health professional from Canada on 2012-08-27
Patient: male
Reactions: Abdominal Pain, Productive Cough, Pruritus, Nasopharyngitis, Metastases To Liver, Pyrexia, Faecal Volume Increased, Hot Flush, Fatigue, Cough, Decreased Appetite, Abdominal Pain Lower, Vomiting, Pain in Extremity, Nausea, Abnormal Faeces, Injection Site Pain, Skin Plaque, Flushing, Abdominal Mass, Arthralgia, Gastrointestinal Neoplasm, Diarrhoea, Dysphonia, Neoplasm Malignant, Visual Impairment, Vision Blurred, Lacrimation Increased, Depressed Mood
Drug(s) suspected as cause:
Sandostatin
Dosage: 100 ug, tid
Start date: 2010-03-01
Sandostatin
Indication: Neuroendocrine Tumour
End date: 2008-01-01
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2010-03-13
Sandostatin LAR
Dosage: 40 mg, every 4 weeks
Sandostatin LAR
Dosage: 30 mg every 4 weeks
Other drugs received by patient: Antibiotics; Morphine
Possible Sandostatin side effects in female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-27
Patient: female
Reactions: Abdominal Pain, Fatigue, Diarrhoea, Arthralgia, Pain in Extremity, Insomnia
Drug(s) suspected as cause:
Sandostatin
Dosage: 50 ug, bid
Indication: Acromegaly
Start date: 2009-07-07
Sandostatin LAR
Dosage: 20 mg, monthly
Indication: Acromegaly
Start date: 2009-07-24
Sandostatin LAR
Dosage: 20 mg, every 4 weeks
Sandostatin LAR
Dosage: 30 mg, monthly
Possible Sandostatin side effects in male
Reported by a physician from France on 2012-08-24
Patient: male
Reactions: Intestinal Ischaemia, Thrombosis, Abdominal Pain, Lymphadenopathy, Intestinal Obstruction, Intestinal Stenosis, Mucosal Inflammation, Incorrect Drug Administration Duration, Abdominal Distension, Small Intestinal Stenosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Arixtra
Dosage: 2.5mg per day
Indication: Product Used FOR Unknown Indication
Start date: 2012-01-01
End date: 2012-03-01
Atarax
Dosage: 50mg per day
Indication: Product Used FOR Unknown Indication
Codeine Syrup
Indication: Product Used FOR Unknown Indication
Start date: 2012-02-01
End date: 2012-03-01
Imodium
Indication: Product Used FOR Unknown Indication
Start date: 2012-02-01
End date: 2012-03-01
Nexium
Dosage: 40mg per day
Indication: Product Used FOR Unknown Indication
Quetiapine
Dosage: 2unit at night
Administration route: Oral
Indication: Schizophrenia
Start date: 2012-02-06
End date: 2012-03-01
Sandostatin
Indication: Product Used FOR Unknown Indication
Start date: 2012-02-01
End date: 2012-03-01
Tranxene
Indication: Delirium
Start date: 2012-01-01
End date: 2012-03-01
Other drugs received by patient: Acetaminophen; Flagyl; Acetaminophen; Augmentin '500'; Chlorpromazine HCL; Clozapine; Rocephin; Spasfon; Haloperidol Lactate
Possible Sandostatin side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-24
Patient: male
Reactions: Intestinal Ischaemia, Blood Iron Decreased, Abdominal Pain, Thrombosis, Lymphadenopathy, Intestinal Obstruction, Gastrointestinal Stenosis, Blood Magnesium Decreased, Transferrin Saturation Decreased, Gastrointestinal Ulcer, Diarrhoea, Colonic Stenosis, Gastrointestinal Disorder, Hypoalbuminaemia, Abdominal Distension, Impaired Gastric Emptying, Small Intestinal Stenosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Arixtra
Start date: 2012-01-01
Arixtra
Dosage: 2.5 mg, daily
Start date: 2012-03-06
End date: 2012-03-01
Atarax
Codeine Syrup
Esomeprazole Sodium
Dosage: 40 mg, daily
Start date: 2012-03-06
Imodium
Dosage: 2 df, tid
End date: 2012-03-01
Imodium
Dosage: 3 df, qid
Start date: 2012-03-06
Quetiapine
Dosage: 600 mg, 1h before the dinner
Start date: 2012-02-06
Quetiapine
Dosage: 600 mg, in the evening
Start date: 2012-03-06
Sandostatin
Start date: 2012-02-01
End date: 2012-03-01
Sandostatin
Dosage: 100 mcg , bid
Start date: 2012-03-06
End date: 2012-03-01
Tranxene
Dosage: 5 mg, in the evening
Start date: 2012-03-06
Tranxene
Dosage: 50 mg, tid
Start date: 2012-01-01
End date: 2012-03-01
Other drugs received by patient: Spasfon; Chlorpromazine HCL; Acetaminophen; Haloperidol Lactate; Augmentin '500'
Possible Sandostatin side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-23
Patient: male
Reactions: Intestinal Ischaemia, Abdominal Pain, Abdominal Distension, Intestinal Obstruction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Acetaminophen
Indication: Product Used FOR Unknown Indication
Start date: 2012-02-02
Acetaminophen
Indication: Product Used FOR Unknown Indication
Arixtra
Indication: Product Used FOR Unknown Indication
Start date: 2012-03-06
End date: 2012-03-01
Arixtra
Start date: 2012-01-27
End date: 2012-03-01
Atarax
Dosage: evening
Indication: Product Used FOR Unknown Indication
Start date: 2012-03-06
Chlorpromazine HCL
Indication: Product Used FOR Unknown Indication
Start date: 2012-01-27
Codeine
Indication: Product Used FOR Unknown Indication
Start date: 2012-02-01
End date: 2012-03-01
Flagyl
Indication: Product Used FOR Unknown Indication
Imodium
Start date: 2012-02-02
Imodium
Indication: Product Used FOR Unknown Indication
Start date: 2012-03-06
End date: 2012-03-01
Nexium
Indication: Product Used FOR Unknown Indication
Start date: 2012-03-06
Quetiapine Fumarate
Administration route: Oral
Indication: Schizophrenia
Start date: 2012-02-06
Quetiapine Fumarate
Administration route: Oral
Start date: 2012-03-06
Rocephin
Indication: Product Used FOR Unknown Indication
Sandostatin
Dosage: 1 in the morning and 1 in the evening
Start date: 2012-03-01
End date: 2012-03-01
Sandostatin
Indication: Product Used FOR Unknown Indication
Start date: 2012-02-01
End date: 2012-03-01
Spasfon
Indication: Product Used FOR Unknown Indication
Start date: 2012-02-02
Tranxene
Dosage: in the evening
Indication: Product Used FOR Unknown Indication
Start date: 2012-03-06
Tranxene
Start date: 2012-01-27
End date: 2012-03-01
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-08-22
Patient: male
Reactions: Abdominal Pain, Nausea, Blood Pressure Systolic Increased, Flatulence, Gastrointestinal Inflammation, Biliary Colic, Diarrhoea, Dizziness
Drug(s) suspected as cause:
Sandostatin
Sandostatin LAR
Dosage: 20 mg, qmo
Indication: Colitis Microscopic
Start date: 2010-10-18
Other drugs received by patient: Budesonide; Lomotil
Possible Sandostatin side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-20
Patient: male
Reactions: Abdominal Pain, Intestinal Ischaemia, Abdominal Distension, Intestinal Obstruction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Acetaminophen
Indication: Product Used FOR Unknown Indication
Acetaminophen
Indication: Product Used FOR Unknown Indication
Start date: 2012-02-02
Arixtra
Start date: 2012-03-06
End date: 2012-03-01
Arixtra
Indication: Product Used FOR Unknown Indication
Start date: 2012-01-27
End date: 2012-03-01
Atarax
Dosage: evening
Indication: Product Used FOR Unknown Indication
Start date: 2012-03-06
Chlorpromazine HCL
Indication: Product Used FOR Unknown Indication
Start date: 2012-01-27
Codeine
Indication: Product Used FOR Unknown Indication
Start date: 2012-02-01
End date: 2012-03-01
Flagyl
Indication: Product Used FOR Unknown Indication
Imodium
Indication: Product Used FOR Unknown Indication
Start date: 2012-03-06
End date: 2012-03-01
Imodium
Start date: 2012-02-02
Nexium
Indication: Product Used FOR Unknown Indication
Start date: 2012-03-06
Quetiapine Fumarate
Administration route: Oral
Start date: 2012-02-06
Quetiapine Fumarate
Administration route: Oral
Indication: Schizophrenia
Start date: 2012-03-06
Rocephin
Indication: Product Used FOR Unknown Indication
Sandostatin
Indication: Product Used FOR Unknown Indication
Start date: 2012-02-01
End date: 2012-03-01
Sandostatin
Dosage: 1 in the morning and 1 in the evening
Start date: 2012-03-01
End date: 2012-03-01
Spasfon
Indication: Product Used FOR Unknown Indication
Start date: 2012-02-02
Tranxene
Dosage: in the evening
Indication: Product Used FOR Unknown Indication
Start date: 2012-03-06
Tranxene
Start date: 2012-01-27
End date: 2012-03-01
Possible Sandostatin side effects in female
Reported by a health professional (non-physician/pharmacist) from Belgium on 2012-08-17
Patient: female
Reactions: Death, Abdominal Pain, Confusional State, Neoplasm Malignant, Diarrhoea
Adverse event resulted in: death
Drug(s) suspected as cause:
Sandostatin
Start date: 2012-06-01
Sandostatin LAR
Dosage: 30 mg, monthly
Indication: Neuroendocrine Tumour
Start date: 2012-06-29
Possible Sandostatin side effects in male
Reported by a consumer/non-health professional from Canada on 2012-08-16
Patient: male
Reactions: Jaundice, Abdominal Pain, Blood Bilirubin Increased, Confusional State, Agitation, Weight Decreased, Bile Duct Obstruction, Urinary Incontinence, Constipation, Loss of Consciousness, Malaise, Fatigue, Pleural Effusion, Cardiac Failure Congestive, Cough, Decreased Appetite, Lethargy, Blood Pressure Increased, Dyspnoea, Restlessness, Pain in Extremity, Ascites, Discomfort, Heart Rate Decreased, Abdominal Mass, Syncope, Micturition Disorder, Joint Swelling, Urine Colour Abnormal, Dehydration, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Sandostatin LAR
Dosage: 30 mg, every 3 weeks
Sandostatin LAR
Dosage: 20 mg, once in a month
Indication: Neuroendocrine Tumour
Start date: 2011-02-28
Other drugs received by patient: Sutent
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-08-14
Patient: male
Reactions: Abdominal Pain, Dyspnoea, Blood Pressure Systolic Increased, Suffocation Feeling, Wheezing, Rhinorrhoea, Injection Site Pain, Diarrhoea, Crepitations, Bronchitis, Bradycardia, Asthenia, Cough, Blood Pressure Diastolic Decreased, Influenza
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: 50 ug, tid
Indication: Carcinoid Tumour
Start date: 2011-06-23
Sandostatin
Dosage: 50 ug, tid
End date: 2011-07-05
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Indication: Carcinoid Tumour
Start date: 2011-07-14
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Start date: 2011-07-15
Other drugs received by patient: Dicyclomine; Bisoprolol; Metoprolol
Possible Sandostatin side effects in male
Reported by a consumer/non-health professional from Canada on 2012-08-06
Patient: male
Reactions: Blood Bilirubin Increased, Confusional State, Weight Decreased, Abdominal Pain, Agitation, Jaundice, Bile Duct Obstruction, Urinary Incontinence, Constipation, Loss of Consciousness, Fatigue, Malaise, Pleural Effusion, Cough, Decreased Appetite, Lethargy, Cardiac Failure Congestive, Blood Pressure Increased, Dyspnoea, Pain in Extremity, Restlessness, Discomfort, Ascites, Syncope, Abdominal Mass, Heart Rate Decreased, Joint Swelling, Micturition Disorder, Urine Colour Abnormal, Dehydration, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Sandostatin LAR
Dosage: 20 mg, once in a month
Indication: Neuroendocrine Tumour
Start date: 2011-02-28
Sandostatin LAR
Dosage: 30 mg, every 3 weeks
Other drugs received by patient: Sutent
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-08-03
Patient: male
Reactions: Abdominal Pain, Nasopharyngitis, Pruritus, Metastases To Liver, Faecal Volume Increased, Fatigue, Hot Flush, Decreased Appetite, Abdominal Pain Lower, Vomiting, Nausea, Pain in Extremity, Abnormal Faeces, Injection Site Pain, Skin Plaque, Flushing, Abdominal Mass, Diarrhoea, Gastrointestinal Neoplasm, Neoplasm Malignant, Dysphonia, Arthralgia, Visual Impairment, Vision Blurred, Lacrimation Increased, Depressed Mood
Drug(s) suspected as cause:
Sandostatin
Dosage: 100 ug, tid
Start date: 2010-03-01
Sandostatin
Indication: Neuroendocrine Tumour
End date: 2008-01-01
Sandostatin LAR
Dosage: 40 mg, every 4 weeks
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2010-03-13
Sandostatin LAR
Dosage: 30 mg every 4 weeks
Other drugs received by patient: Morphine Sulfate
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-07-24
Patient: female
Reactions: Abdominal Pain, Blood Growth Hormone Increased, Blood Pressure Systolic Increased, Mass, Necrosis, Acne, Loss of Consciousness, Abdominal Pain Upper, Fatigue, Arthralgia, Injection Site Calcification, Dizziness, Asthenia
Drug(s) suspected as cause:
Sandostatin
Dosage: 3 df, (3 times per night)
Indication: Headache
Sandostatin LAR
Dosage: 40 mg every 3 weeks
Indication: Acromegaly
Start date: 2004-07-15
Other drugs received by patient: Avalide; Avapro
Possible Sandostatin side effects in male
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-07-23
Patient: male
Reactions: Inappropriate Schedule of Drug Administration, Abdominal Pain, Blood Pressure Systolic Increased, Flatulence, Hyperhidrosis, Abdominal Pain Upper, Diarrhoea, Feeling of Body Temperature Change, Asthenia
Drug(s) suspected as cause:
Sandostatin
Dosage: unk ukn, unk
Start date: 2010-08-02
Sandostatin
Dosage: unk ukn, unk
Indication: Neuroendocrine Tumour
Start date: 2009-08-24
Sandostatin LAR
Dosage: 10 mg, every 4 weeks
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2010-09-07
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-07-18
Patient: male
Reactions: Abdominal Pain, Dyspnoea, Suffocation Feeling, Blood Pressure Systolic Increased, Wheezing, Rhinorrhoea, Injection Site Pain, Diarrhoea, Crepitations, Bronchitis, Bradycardia, Asthenia, Blood Pressure Diastolic Decreased, Cough, Influenza
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: 50 ug, tid
End date: 2011-07-05
Sandostatin
Dosage: 50 ug, tid
Indication: Carcinoid Tumour
Start date: 2011-06-23
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Indication: Carcinoid Tumour
Start date: 2011-07-14
Other drugs received by patient: Bisoprolol Fumarate; Metoprolol Succinate; Dicyclomine
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-07-17
Patient: female
Reactions: Abdominal Pain, Contusion, Blood Pressure Systolic Increased, Metastases To Liver, Diarrhoea, Gastrointestinal Carcinoma, Fall, RIB Fracture
Drug(s) suspected as cause:
Sandostatin
Dosage: 100 ug, once/single
Indication: Carcinoid Tumour
Start date: 2010-09-30
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Carcinoid Tumour
Start date: 2010-10-28
End date: 2011-08-11
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-07-17
Patient: female
Reactions: Abdominal Pain, Flatulence, Pain, Constipation, Fall, Abdominal Pain Upper, Herpes Zoster, Fatigue, Malaise, Dizziness, Abdominal Distension, Anuria, Blood Pressure Increased, Back Pain, Humerus Fracture, Gastrointestinal Motility Disorder, Vomiting, Pain in Extremity, Nausea, Flushing, Arthralgia, Diarrhoea, Ocular Hyperaemia, Flank Pain, Vision Blurred, Asthenia, Neuralgia, Abdominal Adhesions
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: 100 ug, tid
Indication: Small Intestine Carcinoma
Sandostatin LAR
Dosage: 30 mg, qmo
Sandostatin LAR
Dosage: 30 mg, qmo
Sandostatin LAR
Dosage: 30 mg, tiw
Indication: Small Intestine Carcinoma
Start date: 2009-05-26
Sandostatin LAR
Dosage: 30 mg, tiw
Sandostatin LAR
Dosage: 30 mg, tiw
Other drugs received by patient: Xeloda; Capecitabine
Possible Sandostatin side effects in female
Reported by a physician from Canada on 2012-06-28
Patient: female
Reactions: Abdominal Pain, Blood Pressure Increased, Blood Growth Hormone Increased, Mass, Blood Pressure Systolic Increased, Necrosis, Acne, Loss of Consciousness, Abdominal Pain Upper, Fatigue, Injection Site Calcification, Arthralgia, Dizziness, Asthenia
Drug(s) suspected as cause:
Sandostatin
Dosage: 3 df, (3 times per night)
Indication: Headache
Sandostatin LAR
Dosage: 40 mg every 3 weeks
Indication: Acromegaly
Start date: 2004-07-15
Other drugs received by patient: Avalide
Possible Sandostatin side effects in male
Reported by a consumer/non-health professional from Canada on 2012-06-22
Patient: male
Reactions: Abdominal Pain, Headache, Erythema, Oedema Peripheral, Blood Pressure Abnormal, Nervousness, Blood Pressure Systolic Decreased, Chest Discomfort, Cardiac Murmur, Blood Urine Present, Pain in Extremity, Hypoaesthesia, Tremor, Carcinoid Tumour of THE Pancreas, Flushing, Heart Rate Decreased, Vision Blurred, Fall, Abdominal Pain Upper, Hepatomegaly, Chest Pain, Dizziness, Heart Rate Irregular, Dyspnoea, Vomiting, Nausea, Retching, Lung Neoplasm, Burning Sensation, Diarrhoea, Heart Rate Increased, Visual Impairment, Hypertension, Blood Pressure Fluctuation, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: 5 ug, tid
Indication: Carcinoid Tumour of THE Small Bowel
Start date: 2010-04-22
Sandostatin LAR
Dosage: 30 mg, every 3 weeks
Sandostatin LAR
Dosage: 30 mg, every 3 weeks
Start date: 2010-08-25
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Small Intestine Carcinoma
Start date: 2010-08-22
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Other drugs received by patient: Propranolol; Lyrica; Codeine; Lantus; Rasilez D; Ranitidine
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-06-19
Patient: male
Reactions: Abdominal Pain, Headache, Erythema, Oedema Peripheral, Blood Pressure Abnormal, Nervousness, Blood Pressure Systolic Decreased, Chest Discomfort, Blood Urine Present, Cardiac Murmur, Pain in Extremity, Hypoaesthesia, Flushing, Heart Rate Decreased, Vision Blurred, Fall, Abdominal Pain Upper, Hepatomegaly, Chest Pain, Dizziness, Heart Rate Irregular, Vomiting, Dyspnoea, Retching, Nausea, Lung Neoplasm, Burning Sensation, Diarrhoea, Heart Rate Increased, Visual Impairment, Asthenia, Blood Pressure Fluctuation, Hypertension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: 5 ug, tid
Indication: Carcinoid Tumour of THE Small Bowel
Start date: 2010-04-22
Sandostatin LAR
Dosage: 30 mg, every 3 weeks
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Small Intestine Carcinoma
Start date: 2010-08-22
Sandostatin LAR
Dosage: 30 mg, every 3 weeks
Start date: 2010-08-25
Other drugs received by patient: Propranolol; Lyrica; Lantus; Rasilez D; Codeine; Ranitidine
Possible Sandostatin side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-18
Patient: female
Reactions: Abdominal Pain
Drug(s) suspected as cause:
Sandostatin
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-06-01
Patient: male
Reactions: Abdominal Pain, Pruritus, Metastases To Liver, Faecal Volume Increased, Fatigue, Hot Flush, Decreased Appetite, Abdominal Pain Lower, Vomiting, Nausea, Pain in Extremity, Abnormal Faeces, Injection Site Pain, Skin Plaque, Flushing, Abdominal Mass, Arthralgia, Neoplasm Malignant, Dysphonia, Gastrointestinal Neoplasm, Diarrhoea, Visual Impairment, Vision Blurred, Lacrimation Increased, Depressed Mood
Drug(s) suspected as cause:
Sandostatin
Dosage: 100 ug, tid
Start date: 2010-03-01
Sandostatin
Indication: Neuroendocrine Tumour
End date: 2008-01-01
Sandostatin LAR
Dosage: 30 mg every 4 weeks
Sandostatin LAR
Dosage: 40 mg, every 4 weeks
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2010-03-13
Other drugs received by patient: Morphine
Possible Sandostatin side effects in male
Reported by a consumer/non-health professional from Canada on 2012-05-29
Patient: male
Reactions: Abdominal Pain, Dyspnoea, Suffocation Feeling, Blood Pressure Systolic Increased, Wheezing, Injection Site Pain, Rhinorrhoea, Diarrhoea, Crepitations, Bronchitis, Bradycardia, Asthenia, Blood Pressure Diastolic Decreased, Cough, Influenza
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: 50 ug, tid
Indication: Carcinoid Tumour
Start date: 2011-06-23
Sandostatin
Dosage: 50 ug, tid
End date: 2011-07-05
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Indication: Carcinoid Tumour
Start date: 2011-07-14
Other drugs received by patient: Dicyclomine; Bisoprolol Fumarate
Possible Sandostatin side effects in female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-05-25
Patient: female
Reactions: Back Pain, Blood Pressure Increased, Abdominal Pain, Renal Disorder, Pain, Breakthrough Pain, Injection Site Pain, Laceration, Neoplasm Progression, Fall, Dysgeusia, Malaise, Spinal Compression Fracture, Neoplasm Malignant, Dehydration, Oedema, Gait Disturbance, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Indication: Metastatic Carcinoid Tumour
Start date: 2011-01-20
End date: 2011-01-23
Sandostatin LAR
Dosage: 20 mg, qmo
Sandostatin LAR
Dosage: 20 mg, every four weeks
End date: 2012-02-22
Sandostatin LAR
Dosage: 20 mg, every 4 weeks
Sandostatin LAR
Dosage: 20 mg, qmo
Sandostatin LAR
Dosage: 20 mg, every 4 weeks
Indication: Metastatic Carcinoid Tumour
Start date: 2011-01-24
Other drugs received by patient: Fentanyl-100; Dexamethasone; Dilaudid
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-05-25
Patient: male
Reactions: Abdominal Pain, Headache, Fall, Erythema, Abdominal Pain Upper, Hepatomegaly, Chest Pain, Oedema Peripheral, Dizziness, Heart Rate Irregular, Blood Pressure Abnormal, Nervousness, Blood Pressure Systolic Decreased, Blood Urine Present, Vomiting, Chest Discomfort, Dyspnoea, Cardiac Murmur, Pain in Extremity, Nausea, Retching, Lung Neoplasm, Hypoaesthesia, Burning Sensation, Flushing, Heart Rate Decreased, Diarrhoea, Heart Rate Increased, Vision Blurred, Hypertension, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: 5 ug, tid
Indication: Carcinoid Tumour of THE Small Bowel
Start date: 2010-04-22
Sandostatin LAR
Dosage: 30 mg, every 3 weeks
Start date: 2010-08-25
Sandostatin LAR
Dosage: 30 mg, every 3 weeks
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Small Intestine Carcinoma
Start date: 2010-08-22
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Other drugs received by patient: Propranolol; Codeine Sulfate; Lantus; Rasilez D; Lyrica; Ranitidine
Possible Sandostatin side effects in female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-05-22
Patient: female
Reactions: Blood Pressure Increased, Back Pain, Abdominal Pain, Renal Disorder, Pain, Injection Site Pain, Laceration, Breakthrough Pain, Fall, Dysgeusia, Malaise, Spinal Compression Fracture, Neoplasm Malignant, Dehydration, Oedema, Gait Disturbance, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Indication: Metastatic Carcinoid Tumour
Start date: 2011-01-20
End date: 2011-01-23
Sandostatin LAR
Dosage: 20 mg, qmo
Sandostatin LAR
Dosage: 20 mg, every 4 weeks
Indication: Metastatic Carcinoid Tumour
Start date: 2011-01-24
Sandostatin LAR
Dosage: 20 mg, qmo
Sandostatin LAR
Dosage: 20 mg, every 4 weeks
Sandostatin LAR
Dosage: 20 mg, every four weeks
Other drugs received by patient: Dexamethasone; Dilaudid; Fentanyl-100
Possible Sandostatin side effects in female
Reported by a physician from Canada on 2012-05-18
Patient: female
Reactions: Abdominal Pain, Blood Growth Hormone Increased, Blood Pressure Systolic Increased, Mass, Necrosis, Acne, Abdominal Pain Upper, Fatigue, Injection Site Calcification, Arthralgia, Asthenia
Drug(s) suspected as cause:
Sandostatin
Dosage: 3 df, (3 times per night)
Indication: Headache
Sandostatin LAR
Dosage: 40 mg every 3 weeks
Indication: Acromegaly
Start date: 2004-07-15
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-05-18
Patient: female
Reactions: Abdominal Pain, Metastases To Liver, Injection Site Haematoma, Pain, Neoplasm Progression, Blood Calcium Increased, Injection Site Swelling, Stasis Dermatitis, Constipation, Erythema, Malaise, Injection Site Erythema, Injection Site Induration, Oedema Peripheral, Abdominal Distension, Injection Site Mass, Injection Site Pain, Skin Plaque, Blood Parathyroid Hormone Increased, Flushing, Neoplasm Malignant, Joint Swelling, Alopecia
Drug(s) suspected as cause:
Sandostatin
Dosage: 1 ml, tid
Indication: Neuroendocrine Tumour
Start date: 2010-04-01
Sandostatin
Dosage: 1.5 ml, tid
Sandostatin LAR
Dosage: 60 mg, every 4 weeks
Sandostatin LAR
Dosage: 40 mg, every four weeks
Indication: Neuroendocrine Tumour
Start date: 2010-12-20
Other drugs received by patient: Fragmin
Possible Sandostatin side effects in female
Reported by a physician from Canada on 2012-05-14
Patient: female
Reactions: Abdominal Pain, Flatulence, Pain, Constipation, Fall, Abdominal Pain Upper, Herpes Zoster, Fatigue, Malaise, Abdominal Distension, Dizziness, Back Pain, Blood Pressure Increased, Humerus Fracture, Vomiting, Nausea, Pain in Extremity, Flushing, Diarrhoea, Arthralgia, Ocular Hyperaemia, Flank Pain, Vision Blurred, Asthenia, Neuralgia, Abdominal Adhesions
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: 100 ug, tid
Indication: Small Intestine Carcinoma
Sandostatin LAR
Dosage: 30 mg, qmo
Sandostatin LAR
Dosage: 30 mg, every 3 weeks
Sandostatin LAR
Dosage: 30 mg, qmo
Sandostatin LAR
Dosage: 30 mg, tiw
Indication: Small Intestine Carcinoma
Start date: 2009-05-26
Sandostatin LAR
Dosage: 30 mg, every three weeks
Other drugs received by patient: Xeloda; Capecitabine
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-05-09
Patient: male
Reactions: Weight Decreased, Abdominal Pain, Nasopharyngitis, Mouth Ulceration, Skin Burning Sensation, Oropharyngeal Pain, Erythema, Gastritis, Haematemesis, Abdominal Discomfort, Hot Flush, Fatigue, Injection Site Induration, Decreased Appetite, Cough, Injection Site Mass, Vomiting, Stomatitis, Nausea, Injection Site Pain, Diarrhoea, Hypophagia, Rash Maculo-Papular, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: 500 ug, bid
Start date: 2011-08-25
Sandostatin
Dosage: 150 ug, bid
Start date: 2011-02-14
End date: 2011-02-17
Sandostatin
Dosage: 250 ug, bid
Start date: 2011-06-08
Sandostatin
Dosage: 500 ug, bid
Start date: 2011-08-25
Sandostatin
Dosage: 100 ug, tid
Indication: Neuroendocrine Tumour
Start date: 2011-02-01
End date: 2011-02-14
Sandostatin
Dosage: 500 ug, tid
Sandostatin LAR
Dosage: 40 mg, every three weeks
End date: 2011-06-08
Sandostatin LAR
Dosage: 30 mg, tiw
Sandostatin LAR
Dosage: 40 mg every three weeks
End date: 2011-05-21
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Indication: Neuroendocrine Tumour
Start date: 2009-09-10
Sandostatin LAR
Dosage: 40 mg, every 4 weeks
Sandostatin LAR
Dosage: 40 mg, qmo
Other drugs received by patient: Mesalamine; Insulin; Aspirin; Gravol TAB; Fragmin; Pantoprazole Sodium
Page 1 Next >>
|
